125 related articles for article (PubMed ID: 12581024)
1. Multifocal transitional cell carcinoma in a patient with hereditary nonpolyposis colon cancer.
Ong E; Joseph JV; Bramwell SP; Haites NE
BJU Int; 2003 Feb; 91(3):297. PubMed ID: 12581024
[No Abstract] [Full Text] [Related]
2. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Mongiat-Artus P
Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
[No Abstract] [Full Text] [Related]
3. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Burger M
Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
[No Abstract] [Full Text] [Related]
4. Upper urinary tract carcinoma in Lynch syndrome cases.
Crockett DG; Wagner DG; Holmäng S; Johansson SL; Lynch HT
J Urol; 2011 May; 185(5):1627-30. PubMed ID: 21419447
[TBL] [Abstract][Full Text] [Related]
5. Six primary cancers in one Lynch syndrome patient with chronic arsenic exposure.
Chen PC; Chen WC; Chao SC; Lin BW; Lin SC; Chen CJ; Lee JC
J Surg Oncol; 2012 Mar; 105(3):329-30. PubMed ID: 21882197
[No Abstract] [Full Text] [Related]
6. Familial carcinoma of ureters and other genitourinary organs.
Marchetto D; Li FP; Henson DE
J Urol; 1983 Oct; 130(4):772-3. PubMed ID: 6887416
[TBL] [Abstract][Full Text] [Related]
7. Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation.
Jasperson KW; Blazer KR; Lowstuter K; Weitzel JN
Fam Cancer; 2008; 7(4):281-5. PubMed ID: 18176851
[TBL] [Abstract][Full Text] [Related]
8. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
9. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
[TBL] [Abstract][Full Text] [Related]
10. Poorly differentiated transitional cell carcinoma versus leiomyosarcoma of the ureter: different defects in tumour suppressor genes.
Tzen CY; Wu CJ; Huang ZD; Wu TY
Histopathology; 2007 Aug; 51(2):271-3. PubMed ID: 17593211
[No Abstract] [Full Text] [Related]
11. [Metachronous bilateral ureteral cancer in patient with hereditaly nonpolyposis colorectal cancer].
Yamamoto M; Kashiwai H; Hirata N; Matsuki H; Shimizu K; Tanaka N; Ozono S
Nihon Hinyokika Gakkai Zasshi; 2004 Jan; 95(1):63-6. PubMed ID: 14978944
[TBL] [Abstract][Full Text] [Related]
12. [Genetic features of urothelial carcinoma of the bladder and the upper urinary tract].
Cussenot O; Davin JL
Prog Urol; 2003 Nov; 13(5 Suppl 2):1233. PubMed ID: 15816391
[No Abstract] [Full Text] [Related]
13. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
[TBL] [Abstract][Full Text] [Related]
14. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Malats N; Real FX
Eur Urol; 2009 Mar; 55(3):658. PubMed ID: 18584942
[No Abstract] [Full Text] [Related]
16. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Burger M
Eur Urol; 2009 Mar; 55(3):657. PubMed ID: 18584941
[No Abstract] [Full Text] [Related]
17. Familial transitional cell carcinoma of the bladder.
McCullough DL; Lamma DL; McLaughlin AP; Gittes RF
J Urol; 1975 May; 113(5):629-35. PubMed ID: 1127804
[No Abstract] [Full Text] [Related]
18. Familial urinary bladder cancer.
Purtilo DT; McCarthy B; Yang JP; Friedell GH
Semin Oncol; 1979 Jun; 6(2):254-6. PubMed ID: 482963
[No Abstract] [Full Text] [Related]
19. Re: Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
Kirkali Z
J Urol; 1999 Mar; 161(3):926. PubMed ID: 10022724
[No Abstract] [Full Text] [Related]
20. Familial transitional cell carcinoma and the Lynch syndrome II.
Greenland JE; Weston PM; Wallace DM
Br J Urol; 1993 Aug; 72(2):177-80. PubMed ID: 8402022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
